The PDF file includes: Fig. S1 . Purification of the hedgehog ligand and PTCH1. Fig. S2 . Cryo-EM and single-particle analysis workflow. Fig. S3 . FSC plots and 3D reconstruction details. Fig. S4 . Features of the map and the atomic model of the protein. Fig. S5 . Disease-linked mutations in PTCH1 are present within the SSD and SSDL regions of the protein. Fig. S6 . Mutations designed to disrupt sterol binding sites in PTCH1 fail to suppress hedgehog pathway activation. Table S1 . Cryo-EM data collection, single-particle analysis, and model building statistics.
Other Supplementary Material for this manuscript includes the following:
(available at advances.sciencemag.org/cgi/content/full/5/9/eaaw6490/DC1) Movie S1 (.mp4 format). The density elements corresponding to bound sterols in the PTCH1 TM-focused map.
Fig. S2
. Cryo-EM and single-particle analysis workflow. A. The aligned averaged micrograph shows a high quality monodisperse sample of the PTCH1∆-ShhN C24II complex in digitonin. B. The best 2D classes calculated in relion-2.0.b prior to the 3D classification step; 2D class features appear blurred. C. The 3D classification job with 4 classes resulted in a single class with clearly defined secondary structure elements. This class was subjected to further processing using relion-2.0.b and relion-3.0. D. Refinement of the best 3D class after Bayesian particle polishing in relion-3.0 (detailed in the "Material and Methods"), using a mask encompassing the complete complex (orange) resulted in a postprocessed density map at 3.5 Å resolution (full map, green, "F"; FSC 0.143). E. Continued refinement of the same dataset, substituting the full mask with a modified mask excluding the detergent micelle density resulted in a postprocessed map 3.4 Å resolution (no-detergent map, blue, "ND"). F. Continued refinement following the ND map, using the mask covering only the transmembrane region of PTCH1∆ resulted in the postprocessed map at 3.3 Å resolution (transmembrane map, magenta, "TM"). For each map, sharpening with a b-factor of -50 was used in the postprocessing step. Table S1 . B-E. Individual parts of the map shown as mesh, including the regions corresponding to ectodomain 1 ("ECD1"), ectodomain 2 ("ECD2"), complete transmembrane domain bundle ("TM") and the modified hedgehog ligand ShhN C24II . The protein model is shown as ribbon, with side-chain represented with lines (colored by atom type). F. The N-terminal residues of PTCH1∆ (D46-P76) resolved in our 3D reconstruction are shown as green mesh. G. The N-terminus forms an interface with the cytosolic side of the SSD and SSDL portions of the protein. S6 . Mutations designed to disrupt sterol binding sites in PTCH1 fail to suppress hedgehog pathway activation. A-C. The views of the residues L116 (A), M598 (B) and T768 (C), chosen for substitution to a bulky residue (W); the models of the mutants, illustrating the disruption of the sterol sites (represented using the yellow density map and labelled with the numbered circles), were generated using PyMol. D. The luciferase-based reporter assay for hedgehog pathway activation shows that all PTCH1 and PTCH1 (indicated by "") constructs are capable of inhibiting the pathway in transiently transfected PTCH1-/-mouse embryo fibroblasts. All values, including the GFP control, were normalized using the measurements performed using the cells transfect with the empty expression vector. For all measurements, n = 4; for measurements with full-length PTCH1 and mutants, n = 3. All values are significantly different from the GFP control, but not different from each other, based on one way ANOVA (P < 0.001).
Movie S1. The density elements corresponding to bound sterols in the PTCH1 TM-focused map. The movie was generated in Pymol (mset and util.mroll commands with 180 frames), using the TM map shown in Fig. 2B . The map is coloured according to Fig. 2B (SSD is coloured orange, SSDL is coloured blue). The positions of the sterol sites are indicated by yellow mesh over the density map. 
